{
    "clinical_study": {
        "@rank": "42007", 
        "arm_group": [
            {
                "arm_group_label": "Sevoflurane", 
                "arm_group_type": "Experimental", 
                "description": "Sevoflurane will be administered as the maintenance agent of general anesthesia."
            }, 
            {
                "arm_group_label": "Desflurane", 
                "arm_group_type": "Active Comparator", 
                "description": "Desflurane will be administered as the maintenance agent of general anesthesia."
            }
        ], 
        "brief_summary": {
            "textblock": "We want to evaluate the efficacy of the sevoflurane and desflurane for the prevention of\n      catheter-related bladder discomfort."
        }, 
        "brief_title": "Sevoflurane Versus Desflurane for Catheter-related Bladder Discomfort", 
        "completion_date": {
            "#text": "July 2014", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Catheter Site Discomfort", 
            "Complications", 
            "Anesthesia", 
            "Urinary Bladder Neoplasms"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Urinary Bladder Neoplasms", 
                "Neoplasms"
            ]
        }, 
        "detailed_description": {
            "textblock": "The mechanism of catheter-related bladder discomfort is thought to be related to the\n      muscarinic receptor. The volatile anesthetics such as sevoflurane and desflurane are known\n      to block the muscarinic receptor in different ways.\n\n      We want to evaluate the efficacy of the sevoflurane and desflurane for the prevention of\n      catheter-related bladder discomfort."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Patients scheduled for transurethral bladder excision under general anesthesia\n\n          -  ASA I-III\n\n        Exclusion Criteria:\n\n          -  Foley catheter less than 18 Fr.\n\n          -  Patients with obstruction of urinary tract\n\n          -  Patients with neurogenic bladder\n\n          -  Patients with severe obesity\n\n          -  Patients with neurologic disorder\n\n          -  Patients with chronic pain"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "80 Years", 
            "minimum_age": "19 Years"
        }, 
        "enrollment": {
            "#text": "92", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "March 21, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02096224", 
            "org_study_id": "CRBDSevoDes"
        }, 
        "intervention": [
            {
                "arm_group_label": "Sevoflurane", 
                "description": "Sevoflurane will be used.", 
                "intervention_name": "Sevoflurane", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Desflurane", 
                "description": "Desflurane will be used", 
                "intervention_name": "Desflurane", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Desflurane", 
                "Sevoflurane"
            ]
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "March 21, 2014", 
        "location": {
            "contact": {
                "email": "hppark@snu.ac.kr", 
                "last_name": "Hee-Pyoung Park, PhD", 
                "phone": "+821029717647"
            }, 
            "facility": {
                "address": {
                    "city": "Seoul", 
                    "country": "Korea, Republic of"
                }, 
                "name": "Seoul National University of Hospital"
            }, 
            "investigator": [
                {
                    "last_name": "Hyun-Chang Kim, MD", 
                    "role": "Principal Investigator"
                }, 
                {
                    "last_name": "Hee-Pyoung Park, PhD", 
                    "role": "Principal Investigator"
                }
            ], 
            "status": "Not yet recruiting"
        }, 
        "location_countries": {
            "country": "Korea, Republic of"
        }, 
        "number_of_arms": "2", 
        "official_title": "Comparison of the Effects of Sevoflurane and Desflurane on Prevention of Catheter-related Bladder Discomfort", 
        "overall_contact": {
            "email": "onidori1979@gmail.com", 
            "last_name": "Hyun-Chang Kim, MD", 
            "phone": "+821028862876"
        }, 
        "overall_official": {
            "affiliation": "Seoul National University of Hospital", 
            "last_name": "Hee-Pyoung Park, PhD", 
            "role": "Study Chair"
        }, 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "Korea: Institutional Review Board", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "July 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Catheter-related bladder discomfort will be measured at 1 hour postoperatively (0:none, 1:mild, 2:moderate, 3:severe).", 
            "measure": "Catheter-related bladder discomfort", 
            "safety_issue": "No", 
            "time_frame": "1 hour postoperatively"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02096224"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "Catheter-related bladder discomfort will be measured at 1 hour postoperatively (0:none, 1:mild, 2:moderate, 3:severe).", 
                "measure": "Catheter-related bladder discomfort", 
                "safety_issue": "No", 
                "time_frame": "0, 6 and 24 hour postoperatively"
            }, 
            {
                "description": "The degree of nausea will be assessed as none, mild, moderate and severe at 0, 1, 6 and 24 hour postoperatively.", 
                "measure": "Nausea", 
                "safety_issue": "No", 
                "time_frame": "0, 1, 6 and 24 hour postoperatively"
            }, 
            {
                "description": "The degree of vomiting will be assessed as none, mild, moderate and severe at 0, 1, 6 and 24 hour postoperatively.", 
                "measure": "Vomiting", 
                "safety_issue": "No", 
                "time_frame": "0, 1, 6 and 24 hour postoperatively"
            }, 
            {
                "description": "Anxiety score after the admission of operating room will be assessed. (score:0-10)", 
                "measure": "Anxiety", 
                "safety_issue": "No", 
                "time_frame": "0 houe after admission of operating room"
            }, 
            {
                "description": "Agitation will be assessed using Riker sedation-agitated scale at 0 hour after admission of post-anesthesia care unit.", 
                "measure": "Agitation", 
                "safety_issue": "No", 
                "time_frame": "0 hour after admision of post-anesthesia care unit"
            }
        ], 
        "source": "Seoul National University Hospital", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Seoul National University Hospital", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "April 2014", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator, Outcomes Assessor), Primary Purpose: Prevention", 
        "study_type": "Interventional", 
        "verification_date": "March 2014"
    }
}